Molecular Templates, Inc. (NASDAQ: MTEM) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating.
Molecular Templates, Inc. (MTEM)
Last molecular templates, inc. earnings: 11/12 05:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.mtem.com/investor-relations
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
MTEM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MTEM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MTEM alerts
High impacting Molecular Templates, Inc. news events
Weekly update
A roundup of the hottest topics
MTEM
News
- Molecular Templates' Presentations At The 2022 ASCO Annual Meeting Demonstrate Advancement In PD-L1 And HER2 Programs [TheStreet.com]TheStreet.com
- Molecular Templates’ Presentations at the 2022 ASCO Annual Meeting Demonstrate Advancement in PD-L1 and HER2 ProgramsGlobeNewswire
- Molecular Templates to Present at Upcoming Investor ConferencesGlobeNewswire
- Molecular Templates, Inc. (<a href="https://www.marketbeat.com/stocks/NASDAQ/MTEM/price-target/">NASDAQ: MTEM</a>) had its price target lowered by analysts at Stifel Nicolaus from $11.00 to $9.00.MarketBeat
- Molecular Templates, Inc. Reports First Quarter 2022 Financial ResultsGlobeNewswire
MTEM
Earnings
- 5/12/22 - Beat
MTEM
Sec Filings
- 6/21/22 - Form 4
- 6/21/22 - Form 4
- 6/21/22 - Form 4
- MTEM's page on the SEC website